In parallel, to determine if BSO acted directly on the bacteria themselves, we incubated R
10.1016/S0014-5793(01)02519-4 FEBS Lett 94 MizushimaN
BPC-157, short for Body Protection Compound-157, is a synthetic 15-amino acid peptide derived from a protective protein fragment found naturally in human gastric juice
Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)
doi: 10.3389/fendo.2017.00293 56 Beloribi-DjefafliaSVasseurSGuillaumondF
Our genetic test reveals predispositions in nutrient-metabolism pathways (including B12, choline, and methylation genes) that may inform whether lipotropic support aligns with your genetic profile